These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22663168)

  • 21. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial.
    Clarkesmith DE; Pattison HM; Lip GY; Lane DA
    PLoS One; 2013; 8(9):e74037. PubMed ID: 24040156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation.
    Smet L; Heggermont WA; Goossens E; Eeckloo K; Vander Stichele R; De Potter T; De Backer T
    J Adv Nurs; 2018 Nov; 74(11):2577-2587. PubMed ID: 29944735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen.
    Vaanholt MCW; Weernink MGM; von Birgelen C; Groothuis-Oudshoorn CGM; IJzerman MJ; van Til JA
    Patient Educ Couns; 2018 Nov; 101(11):1982-1989. PubMed ID: 30001822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.
    Brown JD; Shewale AR; Talbert JC
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1319-1329. PubMed ID: 27783556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: A systematic review.
    Mohan A; Wanat MA; Abughosh SM
    Expert Rev Cardiovasc Ther; 2019 Jun; 17(6):427-434. PubMed ID: 31100208
    [No Abstract]   [Full Text] [Related]  

  • 26. Patterns and predictors of use of warfarin and other common long-term medications in patients with atrial fibrillation.
    Song X; Sander SD; Varker H; Amin A
    Am J Cardiovasc Drugs; 2012 Aug; 12(4):245-53. PubMed ID: 22775446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey.
    Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):337-343. PubMed ID: 29658327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
    Clarkesmith DE; Pattison HM; Lane DA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008600. PubMed ID: 23736948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.
    Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y;
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
    Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
    Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation.
    Salmasi S; De Vera MA; Safari A; Lynd LD; Koehoorn M; Barry AR; Andrade JG; Deyell MW; Rush K; Zhao Y; Loewen P
    J Am Coll Cardiol; 2021 Dec; 78(24):2395-2404. PubMed ID: 34886959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
    Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S
    J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.
    Mohan A; Majd Z; Trinh T; Paranjpe R; Abughosh SM
    Int J Clin Pharm; 2022 Aug; 44(4):966-974. PubMed ID: 35776377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation.
    Suzuki T; Shiga T; Omori H; Tatsumi F; Nishimura K; Hagiwara N
    J Cardiol; 2017 Sep; 70(3):238-243. PubMed ID: 28007412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.